LFCR

Lifecore Biomedical Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 2/10
  • Value↑ 6/10
Lifecore Biomedical sales and earnings growth
LFCR Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ 0.00%
Lifecore Biomedical gross and profit margin trends
LFCR Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Lifecore Biomedical net debt vs free cash flow
LFCR Risk
Poor
  • Debt / Equity↑ 7.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Lifecore Biomedical stock volatility is higher than the overall market. We give it a Poor risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks